Vanguard Group Inc. Raises Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Vanguard Group Inc. boosted its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 2.7% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 86,335,084 shares of the pharmacy operator's stock after buying an additional 2,279,495 shares during the period. Vanguard Group Inc. owned 9.99% of Walgreens Boots Alliance worth $805,506,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. First Financial Corp IN lifted its stake in Walgreens Boots Alliance by 49.2% in the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator's stock worth $25,000 after purchasing an additional 885 shares in the last quarter. Golden State Wealth Management LLC bought a new position in Walgreens Boots Alliance during the fourth quarter valued at approximately $26,000. Riverview Trust Co increased its stake in Walgreens Boots Alliance by 123.8% in the 4th quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator's stock worth $27,000 after acquiring an additional 1,590 shares during the last quarter. Venturi Wealth Management LLC bought a new stake in Walgreens Boots Alliance in the 4th quarter worth approximately $28,000. Finally, TD Private Client Wealth LLC grew its holdings in shares of Walgreens Boots Alliance by 8,670.3% in the third quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator's stock valued at $29,000 after purchasing an additional 3,208 shares in the last quarter. 58.59% of the stock is owned by institutional investors.

Walgreens Boots Alliance Stock Down 1.1 %

NASDAQ WBA traded down $0.12 on Thursday, reaching $11.06. 22,718,139 shares of the stock traded hands, compared to its average volume of 20,802,565. Walgreens Boots Alliance, Inc. has a 12 month low of $8.08 and a 12 month high of $19.48. The company has a market cap of $9.56 billion, a price-to-earnings ratio of -1.08, a PEG ratio of 1.31 and a beta of 0.62. The company has a fifty day moving average price of $10.78 and a 200-day moving average price of $9.96. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64.

Remove Ads

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last released its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, topping analysts' consensus estimates of $0.38 by $0.13. The company had revenue of $39.50 billion during the quarter, compared to analyst estimates of $37.40 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The firm's revenue for the quarter was up 7.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.66 earnings per share. As a group, research analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the stock. Evercore ISI lifted their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an "in-line" rating in a research note on Monday, January 13th. Bank of America lifted their target price on Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an "underperform" rating in a report on Monday, January 13th. Truist Financial dropped their price objective on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating for the company in a research note on Friday, January 31st. Wolfe Research raised shares of Walgreens Boots Alliance to a "hold" rating in a research note on Monday, February 24th. Finally, Deutsche Bank Aktiengesellschaft cut shares of Walgreens Boots Alliance from a "hold" rating to a "sell" rating and dropped their price target for the stock from $11.00 to $9.00 in a research note on Friday, February 28th. Four investment analysts have rated the stock with a sell rating, seven have given a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, Walgreens Boots Alliance has a consensus rating of "Hold" and a consensus price target of $10.59.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.